BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Clouse RE. Managing functional bowel disorders from the top down: lessons from a well-designed treatment trial. Gastroenterology. 2003;125:249-253. [PMID: 12851889 DOI: 10.1016/s0016-5085(03)00808-4] [Cited by in Crossref: 25] [Cited by in F6Publishing: 21] [Article Influence: 1.3] [Reference Citation Analysis]
Number Citing Articles
1 Daghaghzadeh H, Memar A, Mohamadi Y, Rezakhani N, Safazadeh P, Aghaha S, Adibi P. Therapeutic Effects of Low-dose Bismuth Subcitrate on Symptoms and Health-related Quality of Life in Adult Patients with Irritable Bowel Syndrome: A Clinical Trial. J Res Pharm Pract 2018;7:13-21. [PMID: 29755994 DOI: 10.4103/jrpp.JRPP_17_56] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
2 Good L, Rosario R, Panas R. New therapeutic option for irritable bowel syndrome: Serum-derived bovine immunoglobulin. World J Gastroenterol 2015; 21(11): 3361-3366 [PMID: 25805945 DOI: 10.3748/wjg.v21.i11.3361] [Cited by in CrossRef: 10] [Cited by in F6Publishing: 11] [Article Influence: 1.4] [Reference Citation Analysis]
3 Chao GQ, Zhang S. Effectiveness of acupuncture to treat irritable bowel syndrome: A meta-analysis. World J Gastroenterol 2014; 20(7): 1871-1877 [PMID: 24587665 DOI: 10.3748/wjg.v20.i7.1871] [Cited by in CrossRef: 55] [Cited by in F6Publishing: 41] [Article Influence: 6.9] [Reference Citation Analysis]
4 Patel A, Sayuk GS, Kushnir VM, Gyawali CP. Sensory neuromodulators in functional nausea and vomiting: predictors of response. Postgrad Med J 2013;89:131-6. [PMID: 23112216 DOI: 10.1136/postgradmedj-2012-131284] [Cited by in Crossref: 7] [Cited by in F6Publishing: 5] [Article Influence: 0.7] [Reference Citation Analysis]
5 Clouse RE, Lustman PJ. Use of psychopharmacological agents for functional gastrointestinal disorders. Gut 2005;54:1332-41. [PMID: 16099800 DOI: 10.1136/gut.2004.048884] [Cited by in Crossref: 51] [Cited by in F6Publishing: 46] [Article Influence: 3.0] [Reference Citation Analysis]
6 Halpert A, Dalton CB, Diamant NE, Toner BB, Hu Y, Morris CB, Bangdiwala SI, Whitehead WE, Drossman DA. Clinical response to tricyclic antidepressants in functional bowel disorders is not related to dosage. Am J Gastroenterol 2005;100:664-71. [PMID: 15743366 DOI: 10.1111/j.1572-0241.2005.30375.x] [Cited by in Crossref: 50] [Cited by in F6Publishing: 43] [Article Influence: 2.9] [Reference Citation Analysis]
7 Perelló A, Mearin F. [Pharmacological possibilities for visceral perception modulation]. Gastroenterol Hepatol 2004;27:480-90. [PMID: 15388054 DOI: 10.1016/s0210-5705(03)70508-1] [Reference Citation Analysis]
8 Talley NJ. Antidepressants in IBS: are we deluding ourselves? Am J Gastroenterol 2004;99:921-3. [PMID: 15128361 DOI: 10.1111/j.1572-0241.2004.04128.x] [Cited by in Crossref: 23] [Cited by in F6Publishing: 21] [Article Influence: 1.3] [Reference Citation Analysis]
9 . Aanpak van prikkelbaredarmsyndroom. MFAM 2003;41:307-307. [DOI: 10.1007/bf03058290] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.1] [Reference Citation Analysis]